α-synuclein in the pathophysiology of Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1326

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: α-synuclein in the pathophysiology of Alzheimer’s disease ; volume:14 ; number:1 ; day:11 ; month:6 ; year:2019 ; pages:1-19 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (11.6.2019), 1-19, 12.2019

Creator: Twohig, Daniel
Nielsen, Henrietta M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13024-019-0320-x

URN: urn:nbn:de:101:1-2019110503513992116041

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show object at data provider

Associated

Twohig, Daniel
Nielsen, Henrietta M.
SpringerLink (Online service)

Other Objects (12)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Alzheimer’s Disease

Alzheimer’s Disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Alzheimer’s Disease

Alzheimer’s Disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Alzheimer’s Disease

Alzheimer’s Disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.